Literature DB >> 20224515

International consensus guidelines on the management of cytomegalovirus in solid organ transplantation.

Camille N Kotton1, Deepali Kumar, Angela M Caliendo, Anders Asberg, Sunwen Chou, David R Snydman, Upton Allen, Atul Humar.   

Abstract

Cytomegalovirus (CMV) remains one of the most common infections after solid organ transplantation, resulting in significant morbidity, graft loss, and occasional mortality. Management of CMV varies considerably among transplant centers. A panel of experts on CMV and solid organ transplant was convened by The Infectious Diseases Section of The Transplantation Society to develop evidence and expert opinion-based consensus guidelines on CMV management including diagnostics, immunology, prevention, treatment, drug resistance, and pediatric issues.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20224515     DOI: 10.1097/TP.0b013e3181cee42f

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  133 in total

Review 1.  Management of cytomegalovirus infection in solid organ transplantation.

Authors:  Camille N Kotton
Journal:  Nat Rev Nephrol       Date:  2010-10-26       Impact factor: 28.314

Review 2.  Cytomegalovirus: recent progress in understanding pathogenesis and control.

Authors:  V C Emery
Journal:  QJM       Date:  2011-12-22

3.  Retrospective review of the incidence of cytomegalovirus infection and disease after liver transplantation in pediatric patients: comparison of prophylactic oral ganciclovir and oral valganciclovir.

Authors:  Ashley N Bedel; Trina S Hemmelgarn; Rohit Kohli
Journal:  Liver Transpl       Date:  2012-03       Impact factor: 5.799

4.  Interpreting quantitative cytomegalovirus DNA testing: understanding the laboratory perspective.

Authors:  Colleen S Kraft; Wendy S Armstrong; Angela M Caliendo
Journal:  Clin Infect Dis       Date:  2012-03-12       Impact factor: 9.079

5.  Cytomegalovirus UL97 mutations affecting cyclopropavir and ganciclovir susceptibility.

Authors:  Sunwen Chou; Terry L Bowlin
Journal:  Antimicrob Agents Chemother       Date:  2010-11-01       Impact factor: 5.191

6.  24 weeks of valganciclovir prophylaxis in children after renal transplantation: a 4-year experience.

Authors:  Andres F Camacho-Gonzalez; Julie Gutman; Leonard C Hymes; Traci Leong; Joseph A Hilinski
Journal:  Transplantation       Date:  2011-01-27       Impact factor: 4.939

Review 7.  Cytomegalovirus infection in liver transplant recipients: updates on clinical management.

Authors:  Jasmine Riviere Marcelin; Elena Beam; Raymund R Razonable
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

Review 8.  The biology of cytomegalovirus drug resistance.

Authors:  Morgan Hakki; Sunwen Chou
Journal:  Curr Opin Infect Dis       Date:  2011-12       Impact factor: 4.915

9.  Cytomegalovirus infection in childhood-onset systemic lupus erythematosus.

Authors:  Evelyn V Rozenblyum; Upton D Allen; Earl D Silverman; Deborah M Levy
Journal:  Int J Clin Rheumtol       Date:  2013-02

10.  Incidence, risk factors, and outcomes of delayed-onset cytomegalovirus disease in a large, retrospective cohort of heart transplant recipients.

Authors:  C A Q Santos; D C Brennan; V J Fraser; M A Olsen
Journal:  Transplant Proc       Date:  2014-12       Impact factor: 1.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.